Skip to content
Create startup
FollowFollow EditEdit UpgradeUpgrade
  • Company

Company Rank

0

Country Rank

United States
0

SR Score

0

SR Web

0

SR Social

0

Tags

Chase Pharmaceuticals

Chase Pharmaceuticals is engaged in the clinical development of medically improved treatments for central nervous system (CNS) diseases.

Acquired by Allergan on November 22, 2016

Website: https://www.chasepharmaceuticals.com

Founded: January 01, 2007

Social:

 SR Traffic - Month

 Ahrefs

Chase Pharmaceuticals Competitors

Add Competitor

Startup Industry Description
Medikal
Medikal
 - Medikal.com is a global professional networking platform for the healthcare industry. - Medikal - A professional social network for making ...
TrakMD
TrakMD
 Software, Internet & Computer Services Find & book a doctor - TrakMD is the leading cloud based electronic healt ...
Chemists World
Chemists World
 Healthcare Equipment & Services Online Medical Store in India - Chemists World is one of the best online pharmacie ...
View more competitors»

Chase Pharmaceuticals Funding

Add Funding

Date Round Amount Investors
Feb 18, 2016 Series B $ 3,500,000
Aug 20, 2015 Venture $ 3,000,000
May 12, 2014 Series B $ 21,000,000
View more funding rounds»

Chase Pharmaceuticals Acquisitions

Add Acquisition

Date Acquired Amount
There are no acquisitions.

Chase Pharmaceuticals Products

Add Product

Product Stage Description
There are no products.

Chase Pharmaceuticals Team

Add Team Member

Person Role Period
Kathleen E. Clarence-Smith
Kathleen E. Clarence-Smith
 Founder Unknown to Unknown
Thomas N. Chase
Thomas N. Chase
 Founder Unknown to Unknown

Chase Pharmaceuticals News

Add News

Date Title
Nov 23, 2016 allergan.com - Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Nov 23, 2016 PRNewswire All - Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Nov 22, 2016 streetinsider.com - Allergan (AGN) Acquires Chase Pharmaceuticals in $125M + Milestones Deal
Allergan (AGN) Acquires Chase Pharmaceuticals in $125M + Milestones Deal
View more news»

Chase Pharmaceuticals Statistics

Last Week

Rank

SR Score

Likes

Followers



Last Month

Rank

SR Score

Likes

Followers